16-25140204-G-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_016309.3(LCMT1):c.361G>A(p.Val121Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000845 in 1,609,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016309.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LCMT1 | ENST00000399069.8 | c.361G>A | p.Val121Ile | missense_variant | Exon 4 of 11 | 1 | NM_016309.3 | ENSP00000382021.3 | ||
LCMT1 | ENST00000380962.9 | n.*218G>A | non_coding_transcript_exon_variant | Exon 5 of 12 | 2 | ENSP00000370349.5 | ||||
LCMT1 | ENST00000380962.9 | n.*218G>A | 3_prime_UTR_variant | Exon 5 of 12 | 2 | ENSP00000370349.5 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152176Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000704 AC: 17AN: 241322 AF XY: 0.0000689 show subpopulations
GnomAD4 exome AF: 0.0000467 AC: 68AN: 1456858Hom.: 0 Cov.: 29 AF XY: 0.0000442 AC XY: 32AN XY: 724054 show subpopulations
GnomAD4 genome AF: 0.000447 AC: 68AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.000430 AC XY: 32AN XY: 74466 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.361G>A (p.V121I) alteration is located in exon 4 (coding exon 4) of the LCMT1 gene. This alteration results from a G to A substitution at nucleotide position 361, causing the valine (V) at amino acid position 121 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at